MannKind (MNKD) Plummets 40% After FDA Requests More Trials for Insulin Inhaler
Tweet Send to a Friend
Shares of Mannkind Corp. (NASDAQ: MNKD) are down 40 percent to $5.25 in extended trade on Wednesday after the company ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
